Close Menu

NEW YORK – OraSure Technologies announced on Wednesday the pricing of 8 million shares of its common stock at $11 per share.

Net proceeds from the offering are estimated at approximately $82.5 million, the Bethlehem, Pennsylvania-based company said.

OraSure has also granted the underwriters a 30-day option to purchase up to an additional 1.2 million shares of its common stock.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.